Humana (NYSE:HUM) Reaches New 12-Month Low – What’s Next?

Humana Inc. (NYSE:HUM)’s stock price reached a new 52-week low during mid-day trading on Friday . The company traded as low as $163.11 and last traded at $166.1230, with a volume of 179338 shares changing hands. The stock had previously closed at $166.45.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on HUM shares. Wolfe Research lifted their price target on Humana from $300.00 to $325.00 and gave the company an “outperform” rating in a report on Thursday, January 8th. Raymond James Financial reduced their price objective on shares of Humana from $340.00 to $230.00 and set an “outperform” rating for the company in a research report on Friday, February 13th. Guggenheim reduced their price objective on shares of Humana from $312.00 to $252.00 and set a “buy” rating for the company in a research note on Thursday, February 12th. Zacks Research upgraded shares of Humana from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Finally, Deutsche Bank Aktiengesellschaft set a $180.00 price objective on Humana and gave the stock a “hold” rating in a research note on Friday, February 13th. Seven research analysts have rated the stock with a Buy rating, sixteen have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $225.48.

Humana Trading Up 0.5%

The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. The company has a 50-day moving average price of $204.29 and a 200-day moving average price of $244.61. The company has a market capitalization of $20.08 billion, a price-to-earnings ratio of 17.05, a P/E/G ratio of 1.83 and a beta of 0.44.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, topping the consensus estimate of ($4.01) by $0.05. The business had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.The firm’s revenue was up 11.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Friday, March 27th. Humana’s dividend payout ratio is currently 36.05%.

Insider Transactions at Humana

In related news, insider Sanjay K. Shetty bought 810 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average price of $185.21 per share, with a total value of $150,020.10. Following the completion of the transaction, the insider owned 11,657 shares of the company’s stock, valued at $2,158,992.97. The trade was a 7.47% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Montag A & Associates Inc. lifted its stake in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC increased its stake in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the period. Fideuram Asset Management Ireland dac acquired a new position in Humana in the 4th quarter valued at approximately $27,000. Reflection Asset Management acquired a new position in Humana in the 4th quarter valued at approximately $29,000. Finally, Rosenberg Matthew Hamilton lifted its position in shares of Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 68 shares during the period. Institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.